Open in interactive viewer → charts, metric popovers & call review

Helen of Troy's Q1: Beating Sales, Battling Tariff Tide, and Banking on Refunds

Consumer giant shows sales resilience, but cost inflation from Middle East conflict and tariffs forces reliance on refunds and reinvestment.
HELE · Earnings Call · 2026-07-08

A Strong Start, but Costs Loom Large

Helen of Troy (HELE) reported a solid first quarter of fiscal 2027, with consolidated sales up 8.2% year-over-year—ahead of expectations—driven by broad-based brand momentum. Yet the more compelling story is the divergence between top-line strength and margin pressure. Management explicitly framed the quarter as "a solid start" while cautioning that "this is the first year of a multiyear road map." The company is navigating a "dynamic operating environment," as CEO Scott Uzzell put it,“We cannot control the macros. But we can control how we execute within it.” — George Scott Uzzell, Chief Executive Officer · 2026-07-08

We cannot control the macros. But we can control how we execute within it.

George Scott Uzzell, Chief Executive Officer · 2026-07-08
Sales growth was fueled by wins across Osprey's travel packs, OXO's pet expansion, Braun's blood pressure monitors, and an Olive & June Star Wars collaboration. However, gross margin contracted 110 basis points to 46%, reflecting tariff refund timing and inflationary pressure that more than offset pricing gains. CFO Brian Grass noted, "We are navigating a dynamic operating environment and addressing margin pressure from heightened geopolitical and supply chain disruption."“Consolidated sales increased 8.2% favorable to our expectations.” — Brian L. Grass, Chief Financial Officer · 2026-07-08

Refunds: The New Lever

The pivotal change this quarter is the recognition of Phase 1 tariff refunds—a pretax benefit of $1.8 million recognized in Q1, with $9.2 million now embedded in the full-year outlook. This is a notable shift from the prior April call, where CFO Brian Grass stated, "We have not adjusted our outlook up or down as a result of the conflict."“We have not adjusted our outlook up or down as a result of the conflict.” — Brian Grass, Chief Financial Officer · 2026-04-23 Now, refunds are being used to offset cost inflation, but they're not enough—costs from higher commodity inputs, unfavorable yuan movements, and increased freight due to Middle East disruption are "more than offset" by the refund benefit. The company is also preparing to file claims for Phase 2 refunds and has $71 million in EPA tariffs outstanding. Management plans to reinvest a "large portion" of future refunds back into the business, which is a deliberate pivot toward growth investment after years of cost-cutting. This aligns with the future phase narrative, but the immediate uncertainty around collection timing keeps the outlook conservative.

Supply Chain Disruption and Conservative Guidance

Brian Grass quantified the supply risk: "We have beaten expectations by $25 million in the first quarter, but there is $5 million approximately pulled forward out of Q2, and that leaves about 15 in terms of potential supply risk." He added, "We have line of sight to 2 or 3 pinch points where we may have scarcity of supply," and noted that "the events last night" (likely referring to escalating Middle East tensions) could worsen the situation. The company has deliberately embedded a conservative estimate into its full-year outlook, anticipating low-single-digit sales declines in the second half.

Balance Sheet and Operating Model Overhaul

While profits remain challenged, the balance sheet is improving. Net leverage fell to 3.48x from 3.87x, and total debt was reduced by $716 million using proceeds from the distribution facility sale. The company is also reworking its operating model—appointing five segment GMs and three geo-GMs to push decision-making closer to consumers. This is a strategic bet on brand intimacy and agility, with management expecting faster execution without materially increasing costs. Gross margin fell 110 basis points to 46% in Q1. The stock's recent surge—up 73.7% over the past 90 days—suggests the market sees this as a turning point, even as the company grapples with near-term cost headwinds. The stock remains 88.9% below its 2021 peak, leaving substantial room for recovery if the strategy pays off.

Contrast with Prior Quarters

The shift from pure cost-cutting to growth investment is a clear departure from the prior January call, where CFO Brian Grass said, "We're shifting our focus to revenue improvement versus cost reduction."“We're shifting our focus to revenue improvement versus cost reduction.” — Brian Grass, Chief Financial Officer · 2026-01-08 Now, the company is explicitly reinvesting refunds and overperformance into brand building, innovation, and people—a move that prioritizes long-term health over near-term earnings. However, the earnings guidance of $3.25–$3.75 per share is unchanged, implying the cost pressures are real and the refunds only partially offset them. The company is also raising capex by $2 million, signaling confidence in the growth roadmap. Overall, Helen of Troy's quarter is a mixed bag: sales momentum is real, but the margin profile remains under pressure. The novel inclusion of tariff refunds as an earnings lever, combined with the aggressive operating model transformation, marks a strategic inflection. Whether the sales cadence can hold in the face of supply disruption will be the key test in coming quarters.